baber/WOPTO huggingface dataset:
Patent AU-2011296103-A1 (AU)
Title: Fermentation route for the production of levulinic acid, levulinate esters, valerolactone, and derivatives thereof
Inventor: ZANGHELLINI ALEXANDRE LUC
IPC: C07C53/00
Filed: 2011-08-30
Abstract: The invention provides processes for the conversion of pyruvate obtained from sugars or other carbon sources, to valuable C5 materials such as levulinic acid, levulinate esters, valerolactone, and derivatives thereof.
Patent AU-2011298680-A1 (AU)
Title: Method for manufacturing liner plate for cement industry tube mill
Inventor: LI XIAORU
IPC: B02C17/22
Filed: 2011-08-31
Abstract: A method for manufacturing a liner plate for a cement industry tube mill. The liner plate comprises a stamped liner plate base material formed by a common medium carbon steel plate, and an overlay welded layer formed on the liner plate base material. The method comprises arranging the liner plate on the inner side of the mill cylinder using a high strength sand-cement slurry, an epoxy resin or various inorganic adhesives as fixative agents, or by welding the same locally. The liner plate has the following advantages: under the same standard conditions, its service life is increased to 15000 to 20000 hours, its weight is reduced by 50%, and it saves steel by more than 50%.
Patent AU-2011315903-A1 (AU)
Title: Nucleic acid modulators of CLEC-2
Inventor: LAYZER JULIANA M
IPC: A61K31/7088
Filed: 2011-10-14
Abstract: Provided are ligands which bind to and regulate the function of CLEC-2. Nucleic acid CLEC-2 ligands described herein are able to inhibit CLEC-2 mediated platelet aggregation and may also provide use in regulating CLEC-2-mediated processes such as thrombus formation, tumor metastasis, Iymphangiogenesis, HIV dissemination, inflammatory response, cytokine production and phagocytosis. Also disclosed herein are modulator molecules which can reverse the activity of the CLEC-2 ligand both in vitro and in vivo and ex vivo.
Patent AU-2011326137-A1 (AU)
Title: Bismuth-containing compounds for modulating properties of biologically active agents
Inventor: PRICE JOHN D
IPC: A61K33/24
Filed: 2011-11-08
Abstract: Bismuth-containing compounds include bismuth and a biologically active agent coordinated to the bismuth. The biologically active agent includes at least one heteroatom configured for coordination with the bismuth. Coordination polymers include a polymer matrix that contains a bismuth- containing compound. Methods for modulating a pharmacokinetic property of a biologically active agent include coordinating the biologically active agent to bismuth to form a bismuth-containing compound, and administering the bismuth-containing compound orally to a patient. Methods for treating Parkinson's disease, methods for treating hypothyroidism, methods for treating ulcerative colitis, and methods for treating cancer each include administering a bismuth-containing compound to a patient.
Patent AU-2011332142-A1 (AU)
Title: Wireless power utilization in a local computing environment
Inventor: ARNOLD PETER M
IPC: G01R33/32
Filed: 2011-11-18
Abstract: Various embodiments of a wirelessly powered local computing environment are described. The wireless powered local computing environment includes at least a near field magnetic resonance (NFMR) power supply arranged to wirelessly provide power to any of a number of suitably configured devices. In the described embodiments, the devices arranged to receive power wirelessly from the NFMR power supply must be located in a region known as the near field that extends no further than a distance D of a few times a characteristic size of the NFMR power supply transmission device. Typically, the distance D can be on the order of 1 meter or so.
Patent AU-2011349053-A1 (AU)
Title: Heliostat construction
Inventor: BURTON ALEXANDER IAN
IPC: F24S23/71
Filed: 2011-12-22
Abstract: A parabolic mirror assembly for a heliostat comprising a mirror (14) and a backing support frame (20) for the mirror having elongate frame elements (22, 22a) arranged so that the mirror exhibits a shallow concave parabloid profile, wherein the mirror is secured to the frame elements by an adhesive layer between the frame elements and the mirror, and wherein manufacturing tolerances in the frame and/or mirror are compensated for by variations in the thickness of the adhesive. Also contemplated is a mould for forming a parabolic mirror assembly and method of use, that comprises: a mould body having a parabolic upper surface; and a plurality of recessed portions provided in said surface for receiving a frame below the upper surface; wherein a mirror can be conformably positioned on the upper surface of the mould body and adhesive applied between the frame and mirror is cured to form the mirror assembly.
Patent AU-2012201276-A1 (AU)
Title: Medicine injection devices and methods
Inventor: WYRICK RONDAL E
IPC: A61M5/00
Filed: 2012-03-02
Abstract: A reloadable medicine injector and methods are described in which a barrel with a receiving cavity is adapted to slidably receive a syringe subassembly for axial movement therein. Upon removal of a safety and release of a syringe driver, the syringe driver moves forward and injects the syringe needle. A plurality of penetration controls are shown for controlling injection needle penetration depth. The penetration controls have an abutment and various lengths to provide different needle penetration depth positions. In one form of penetration control a sleeve is used against which the syringe or related parts contact. In another form the front return spring is used as a penetration control. A cushioning ring may be used to reduce syringe breakage. A load distribution and guide ring may be used to distribute loading applied to the syringe and help guide the moving syringe. WO 2006/062788 PCT/US2005/043309 oCo en l -' t L
Patent AU-2012203629-A1 (AU)
Title: Therapeutic methods employing nitric oxide precursors
Inventor: SUMMAR MARSHALL L
IPC: A61K31/195
Filed: 2012-06-21
Abstract: Abstract of the Disclosure Isolated polynucleotide molecules and peptides encoded by these molecules are used in the analysis of human carbamyl phosphate synthetase I phenotypes, as well as in diagnostic and therapeutic applications, relating to a 5 human carbamyl phosphate synthetase I polymorphism. By analyzing genomic DNA or amplified genomic DNA, or amplified cDNA derived from mRNA, it is possible to type a human carbamyl phosphate synthetase I with regard to the human carbamyl phosphate synthetase I polymorphism, for example, in the context of diagnosing and treating hepatic veno-occlusive disease (HVOD) 10 associated with bone marrow transplants. 3454000_1 (GHMoter) P01593AU2 LMfOchondno HO3+NH4+2AT CPSI 0 0 N-ac tyilutarnate cAc" Phshte Aspartic OmithineArginosuccinote ARGinn ASL Urea Fumorote FIG, I $1 .0 4f ADP ox Ph sI ot Carbaoy Phosphate FIG, 2
Patent AU-2012203858-A1 (AU)
Title: Automatic camera identification from a multi-camera video stream
Inventor: GONG XIMIN
IPC: H04N5/262
Filed: 2012-06-29
Abstract: An apparatus and method for receiving a current video frame of a program video having a plurality of scene cuts switching between video segments originating from respective cameras of a plurality of cameras and automatically identifying the camera from which the current video frame originated. The apparatus having a feature database storing predetermined features for a plurality of cameras filming a program video originating from the plurality of cameras, a recognition unit receiving a current video frame of the program video, extracting features from the current video frame, and comparing the features to the previously stored features and a camera model estimator computing an estimated camera model based on corresponding feature pairs and previously stored features, wherein if the estimated camera model is within a predetermined threshold of a stored camera model for one of the plurality of cameras, that camera is identified as originating the current video frame. 3I/q Cut Program 310 Front-End Back-End Occlusion Mask Feature Generator 322 Database 316 Camera Mixer 324 Enhanced Video Recognition Unit Tracking Unit Model Warping Unit Camera Model Estimator 312 indicia Storage Fig. 3
Patent AU-2012216663-A1 (AU)
Title: A control system for a subsea well
Inventor: VOSS ROBERT KARL
IPC: E21B34/04
Filed: 2012-09-05
Abstract: A control system for a subsea well, comprises a tree (1) provided with a hydraulic control supply line (15) for opening a downhole safety valve as a result of hydraulic pressure in the line. A part (17) of the line is carried by a structure (6) which is subject to the pressure of production fluid from the well in use of the system so that the line is separable in response to a failure of the integrity of the structure. (Fig. 1) IJSu -1 -A
Patent AU-2012222502-A1 (AU)
Title: Liquid phase separation of plasmid DNA isoforms and topoisomers
Inventor: LAMMERHOFER MICHAEL
IPC: C12N15/10
Filed: 2012-02-27
Abstract: The invention relates to the use of material comprising a carbamoyl-decorated anion-exchanger ligandwherein a cationic group (C), and a hydrogen donor group (N-H), are connected by a spacer with a length between 3 to 5 atoms, immobilized onto or embedded into a heterogeneous matrix, for the separation of isoforms, topoisomers, oligomeric and multimeric forms of plasmid DNA (p DNA).
Patent AU-2012223494-A1 (AU)
Title: Polymeric acid catalysts and uses thereof
Inventor: GEREMIA JOHN M
IPC: C08F8/00
Filed: 2012-02-27
Abstract: Polymers useful as catalysts in non-enzymatic saccharification processes are provided. Provided are also methods for hydrolyzing cellulosic materials into monosaccharides and/or oligosaccharides using these polymeric acid catalysts.
Patent AU-2012225666-A1 (AU)
Title: Personalized medical management system, networks, and methods
Inventor: ELTON JEFFREY J
IPC: G16H50/80
Filed: 2012-03-05
Abstract: Systems and methods assign therapeutic pathways to members of a network of oncology. The systems and methods allow for storage of disparate information in a database and determine a uniform semantics for all of the stored information. The systems and methods allow for the calculation of treatment pathways based on patient information as well as publicly-available information relating to particular diseases, and for the refinement of those treatment pathways as new information is added. Robot-assisted genomic labs permit automated genetic testing, which is integrated with the system.
Patent AU-2012227348-A1 (AU)
Title: Method for operating multi-clothes styler system
Inventor: MOON TAECHUL
IPC: D06F57/02
Filed: 2012-09-26
Abstract: The method for operating a multi-clothes styler system having a first styler and a second styler each with a hanger for applying vibration to clothes hung therefrom, includes an antiphase control step for controlling a vibration phase of a second hanger of the second styler to become an antiphase of the vibration phase of a first hanger of the first styler, if the first hanger of a first clothes styler and the second hanger of a second clothes styler are operated at the same time, and vibration frequencies of the first hanger and the second hanger are the same, whereby minimizing noise produced from the vibration of a plurality of hangers, and preventing the multi-clothes styler system from damaging due to intense variation to prevent a lifetime thereof from reducing.
Patent AU-2012234908-A1 (AU)
Title: Fluid flow control assembly
Inventor: PIZZATO WALTER ANDREW
IPC: F16K31/53
Filed: 2012-03-28
Abstract: Disclosed herein is a fluid flow control assembly (10, 10'). The assembly comprises a fluid conduit (20), and first (30), second (40) and third (50) valves in fluid flow communication with the fluid conduit (20). An actuator is provided to control opening and closing of the first, second and third valves. The actuator is adapted to provide at least the following configurations of the first valve (30), the second valve (40) and the third valve (50): the first and second valves being in open configurations whilst the third valve is in a closed configuration; and the first and second valves being in closed configurations whilst the third valve is in an open configuration.
Patent AU-2012238593-A1 (AU)
Title: Method and apparatus for removing mercury from waste water from hydrocarbon well stream
Inventor: BROERSEN JOSEPH MARIA
IPC: C02F9/00
Filed: 2012-04-05
Abstract: At least a part of the elemental mercury from a waste stream comprising an aqueous stream containing dissolved elemental mercury is removed at least by steam stripping, to produce a treated aqueous stream comprising less elemental mercury than said waste stream and a waste stream comprising at least a portion of the elemental mercury from said waste stream.
Patent AU-2012248279-A1 (AU)
Title: Bottle
Inventor: NAKAYAMA TADAYORI
IPC: B65D1/02
Filed: 2012-04-26
Abstract: Provided is a bottle which is a cylindrical bottle having a base and made of a synthetic resin material by biaxial stretch blow molding. This bottle is provided with: a contacting section, wherein a base wall part of a base part is positioned on an outer edge; a vertical peripheral wall part extending upwards from the inner side of the contacting section in the radial direction of the bottle; a movable wall part that protrudes from an upper end of the vertical peripheral wall part towards the inner side in the radial direction of the bottle; and an indented peripheral wall part with a diameter that gradually narrows from the inner end of the movable wall part in the radial direction of the bottle to the top of the bottle. A ring-shaped recession indented to face an upward direction is formed, along the peripheral direction, on the movable wall part.
Patent AU-2012257578-A1 (AU)
Title: Therapeutic fusion proteins
Inventor: CHADDOCK JOHN
IPC: C12N15/62
Filed: 2012-05-16
Abstract: The present invention relates to the construction of a new class of Targeted Secretion Inhibitors (TSIs), which comprise a non-cytotoxic protease, translocation peptide and a targeting moiety peptide, wherein the targeting moiety peptide has a free N-terminal domain and a free C-terminal domain; to a single-chain fusion protein precursor thereof, and to a method of activating said single-chain fusion protein precursor.
Patent AU-2012268323-A1 (AU)
Title: Transparent infrared-to-visible up-conversion device
Inventor: SO FRANKY
IPC: H01L51/52
Filed: 2012-06-06
Abstract: Embodiments of the invention are directed to a transparent up-conversion device having two transparent electrodes. In embodiments of the invention, the up-conversion device comprises a stack of layers proceeding from a transparent substrate including an anode, a hole blocking layer, an IR sensitizing layer, a hole transport layer, a light emitting layer, an electron transport layer, a cathode, and an antireflective layer. In an embodiment of the invention, the up-conversion device includes an IR pass visible blocking layer,
Patent AU-2012276908-A1 (AU)
Title: Receptor gene for peptide cancer antigen-specific T cell
Inventor: SUGIYAMA HARUO
IPC: C07K14/725
Filed: 2012-06-20
Abstract: The invention provides the nucleotide sequence and amino acid sequence of the CDR3 domain of the T cell receptor (TCR) gene of a WT1 specific cytotoxic T cell (CTL) against WT1 protein. Also provided are a method for testing for and treating cancer using the nucleotide sequence and amino acid sequence, and a chip, primer set, kit, and device for testing for cancer comprising the nucleotide sequence and amino acid sequence.
Patent AU-2012279202-A1 (AU)
Title: Macrocyclic insulin-degrading enzyme (IDE) inhibitors and uses thereof
Inventor: LIU DAVID R
IPC: C07D259/00
Filed: 2012-06-29
Abstract: Macrocyclic compounds that specifically inhibit insulin degrading enzyme (IDE) are provided. Pharmaceutically acceptable salts, solvates, hydrates, stereoisomers, polymorphs, tautomers, isotopically enriched forms, and prodrugs of the macrocyclic IDE inhibitors are also described. Pharmaceutical compositions are also provided. In vivo and in vitro methods of using the IDE inhibitor, and pharmaceutical compositions comprising the IDE inhibitor, for example, for the inhibition of IDE in a subject exhibiting aberrant IDE activity, impaired insulin signaling, or insulin resistance, for example, a subject having diabetes, are also provided.
Patent AU-2012284192-A1 (AU)
Title: Percutaneous methods for spinal stenosis and foraminal stenosis
Inventor: TRAMBOO TARIQ AHMAD
IPC: A61B17/56
Filed: 2012-07-17
Abstract: The present invention is a method for performing a percutaneous laminoplasty that includes entering a first introducer needle introducing a first tool wire into an epidural space above a selected lamina, entering a first catcher exit needle that that is caught with the first introducer needle and pulled through a patient body and entering a second introducer needle introducing a second tool wire into the epidural space below the selected lamina. The method also includes entering a second catcher exit needle that is caught within the epidural space and pulled through the patient body, moving the caught first introducer needle and the first catcher exit needle back and forth to cut the lamina and moving the caught second introducer needle and the second catcher exit needle back and forth to cut the lamina. There is also a method for performing a percutaneous foraminoplasty.
Patent AU-2012308665-A1 (AU)
Title: Oral care implement and refill head therefor
Inventor: FATTORI JOSEPH
IPC: A61C17/22
Filed: 2012-09-13
Abstract: A refill head (100), and oral care implement incorporating the same, wherein the refill head (100) can be uncoupled from a stem (220) of a handle (200) by withdrawing the refill head (100) from the stem of a handle (200) along the longitudinal axis of the oral care implement, which results in locking members (134) on the refill head (100) disengaging from an engagement rib (230) on the stem (220). The locking members (134) and engagement rib (230) may be aligned with or angled relative to the longitudinal axis of the oral care implement. A portion of the stem may be visible through a portion of the refill head to reinforce the proper connection between the refill head and the handle.
Patent AU-2012316011-A1 (AU)
Title: Cloud management system and method
Inventor: SALSBURG MICHAEL A
IPC: G06F15/16
Filed: 2012-09-27
Abstract: An information technology system having a cloud resource management including a first interface. One or more clouds are connected to the resource management unit. Each cloud has a corresponding second interface adapted to provide a service to a user of the information technology system. The cloud resource management unit further including a first storage unit adapted to store first information required to convert a request for the service from the user in the first interface to a request suitable for the second interface of the corresponding at least one cloud.
Patent AU-2012323398-A1 (AU)
Title: Methods for preparing ruthenium carbene complex precursors and ruthenium carbene complexes
Inventor: KUNZ LINDA A
IPC: C07F15/00
Filed: 2012-10-09
Abstract: A method for preparing a ruthenium carbene complex precursor includes reacting a ruthenium refinery salt with a hydrogen halide to form a ruthenium intermediate, and reacting the ruthenium intermediate with an L-type ligand to form the ruthenium carbene complex precursor. A method for preparing a ruthenium vinylcarbene complex includes converting a ruthenium carbene complex precursor into a ruthenium hydrido halide complex, and reacting the ruthenium hydrido halide complex with a propargyl halide to form the ruthenium carbene complex. A method for preparing a ruthenium carbene complex includes converting a ruthenium carbene complex precursor into a ruthenium carbene complex having a structure (PR
Patent AU-2012335906-A1 (AU)
Title: Energy generation device
Inventor: LEVY GEORGE SAMUEL
IPC: H01L35/30
Filed: 2012-11-07
Abstract: An energy generator capable of transferring heat from a cold region to a hot region, which utilizes the adiabatic temperature difference called lapse rate generated in gas or gas-like particles when a field or an energy potential gradient is applied to the particles. The temperature difference is increased by the thermal conductivity of the particles and lowered by the thermal conductivity of the substrate or container holding the particles. Implementations include semiconductors with a doping gradient or with an externally applied voltage; vapors in contact with their liquids; gases in contact with adsorbing surfaces; polar molecules with electrons in the conduction band. Multilayer devices are described. Applications include, for example, coolers, heaters, electrical generators and photon generators.
Patent AU-2012340483-A1 (AU)
Title: Liquid molding resin with nonswelling mica
Inventor: BABA HIROMITSU
IPC: B29C45/18
Filed: 2012-11-15
Abstract: A liquid molding resin component for use in a reaction injection molding process includes a liquid resin reaction monomer including metathesis polymerizable cycloolefin and a plurality of nonswelling mica. The plurality of nonswelling mica have an average particle size in a range of about 35 micro m to about 500 micro m and have a bulk density in a range of about 0.10 g/ml to about 0.27 g/ml. Further, a liquid resin component system for use in a reaction injection molding process includes a plurality of liquid resin components that each include a reaction monomer including metathesis polymerizable cycloolefin. At least one of the liquid resin components includes a catalyst component of a metathesis polymerization catalyst system and at least one of the liquid resin components includes an activator component of a metathesis polymerization catalyst system, and at least one of the liquid resin components includes a plurality of nonswelling mica having an average particle size in a range of about 35 micro m to about 500 micro m and having a bulk density in a range of about 0.10 g/ml to 0.27 g/ml.
Patent AU-2012345666-A1 (AU)
Title: Targeting microRNAs miR-409-5p, miR-379 and miR-154* to treat prostate cancer bone metastasis and drug resistant lung cancer
Inventor: CHUNG LELAND W K
IPC: A61P35/00
Filed: 2012-11-30
Abstract: The present invention describes methods of treating cancer, cancer metastasis, and drug resistant cancers using miRNA inhibitors; for example, inhibitors of miR-409-5p. Also described are methods of using the miRNA as biomarkers; for example, to predict responsiveness to a cancer drug, to detect a disease state of cancer.
Patent AU-2012356241-A1 (AU)
Title: Dispensing closure
Inventor: PICHRT VLADISLAV
IPC: B65D51/28
Filed: 2012-02-13
Abstract: The dispensing closure consisting of a closure body with dispensing-metering chambers has the dispensing closure body (1) which has in its bottom part at least two chambers (3) passing into an upper guiding part of the body (1) having a form of guides (2), the cross- section of which coincides with the cross-sections of the chambers (3) in the transition point, while in each of the chambers (3) a piston (4) is situated, having in its upper part a lock preventing unintentional twisting-off of the plastic cover (5), and on its bottom side the piston (4) is fitted with a plastic cutter for perforation of the covering foil (6), while the body (1) containing the pistons (4) is sheltered from upside with a rotationally fitted plastic cover (5) featuring a separable lock (7) preventing any intervention, while the chambers (3) are closed from the body (1) downside with a covering foil (6). The chambers (3) of the dispensing closure are shaped in a form of equal-armed triangle, the longest side of which has a form of circular sector. The piston (4) is hollow in the direction from the circular side of the piston (4) towards the centre. The separable lock (7) against intervention is fitted with an attachment ring. The plastic cutter of the piston (4) is shaped as an extension of the circular edge of the piston (4).